Introduction
Nitrated polycyclic aromatic hydrocarbons (nitro-PAHs) are a class of environmental contaminants that are potent mutagenic in bacterial and mammalian cells and carcinogenic in laboratory animals (1, 2) . Recently, 3-nitrobenzathrone (3-nitro-7H-benz[d,e]anthracen-7one, 3-NBA) has been identiˆed in diesel exhaust, airborne particulate matter, and soil and rainwater (3, 5, 6) . 3-NBA is a powerful mutagen in the Ames test (3, 4) and transgenic mouse assay (7) , and genotoxic in human cells (8) (9) (10) . It has also been reported to show speciˆc DNA adduct formation in vitro, in cell culture and in vivo in rodents (11) (12) (13) (14) (15) . Furthermore, 3-NBA is carcinogenic in F344 rats (16) .
3-NBA has direct-acting mutagenicity in Salmonella enterica serovar Typhimurium (S. typhimurium) strains (3, 4) . This chemical is converted by bacterial nitroreductase (NR) to N-hydroxylated and then by Oacetyltransferase (O-AT) to esteriˆed metabolites in S. typhimurium strains YG1021 overexpressing NR and YG1024 overexpressing O-AT (3, 4) . In contrast, although the genotoxic activation of 3-NBA in mammal including humans is mainly via nitroreduction catalyzed by cytosolic xanthine oxidase (17) and microsomal NADPH-cytochrome P450 reductase (18) , and the participation of cytochrome P450 (CYP) enzymes in the oxidative metabolism of 3-NBA has been suggested (19) , there is no direct evidence of the involvement of CYP enzymes in the nitroreduction of 3-NBA. The role of speciˆc CYP enzymes in the metabolic pathways of 
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In the present study, we newly constructed the OY1022 strain by selecting resistant clones of TA1535NR capable of growth in the presence of 1,8dinitropyrene to reduce the direct sensitivity to 3-NBA. Using this strain as a host, we established diŠerent strains expressing four recombinant human CYPs by introducing two plasmids into S. typhimurium OY1022, one carrying both CYP and NPR cDNA in a biocistronic construct under control of an IPTG-inducible double tac promoter and the other, pOA102, carrying O-AT and umuC'-'lacZ fusion genes, and investigated whether any human CYP enzymes are involved in the genotoxic activation of 3-NBA to its metabolites. Genotoxicity of 3-NBA was determined by using SOS/umu assay systems.
Materials and Methods
Chemicals: 3-Nitrobenzanthrone was synthesized as described previously (20) . All other chemicals and reagents were of the highest purity commercially available.
Isolation of a dinitropyrene-resistant clone from the TA1535NR strain: A dinitropyrene-resistant clone was isolated as described by McCoy et al. (21) . Brie‰y, overnight cultures of Salmonella typhimurium TA1535NR (22) were plated onto Columbia base containing 5 mg of 1,8-dinitropyrene/mL. After incubation in the dark for two days, colonies were picked, recloned, and tested for a deep-rough character (sensitivity to crystal violet) (23) and sensitivity to 1,8-DNP on L-agar. In addition, we examined the induction of umuC gene expression by 1,8-DNP using a 1,8-DNPresistant clone harboring pSK1002 and NM2000 (Oacetyltransferase-deˆcient strain). Both strains showed similar sensitivity to 1,8-DNP. Therefore, this 1,8-DNP-resistant clone appeared to have an O-acetyltransferase-deˆcient character. The 1,8-DNP-resistant clone (TA1535NR/1,8-DNP) was designated S. typhimurium OY1022.
Bacterial strains and their construction: The strains and plasmids used and the constructed strains are listed in Table 1 . To establish S. typhimurium tester strains expressing human cytochrome P450 (CYP) and NADPH-cytochrome P450 reductase (NPR) genes, we employed four plasmids: pCW'/1A1/hNPR, pCW'/ 1A2/hNPR, pCW'/1B1/hNPR, and pCW'/3A4/hNPR (provided by Dr. F.P. Guengerich, Vanderbilt University School of Medicine, USA) (24, 25) . These plasmids were then introduced into S. typhimurium TA1535NR/ 1,8-DNP (harboring pOA102) and the resulting strains were referred to as S. typhimurium OY1022/1A1, OY1022/1A2, OY1022/1B1, and OY1022/3A4, respectively (Table 1 ). In a similar way, the parental S. typhimurium OY1022/pCW strain was established by introducing the null vector pCW and pOA102 ( Table 1) .
Determination of expression of CYP and NPR in S. typhimurium OY1022 cells: The expression of diŠerent CYP enzymes and NADPH-cytochrome P450 reductase in S. typhimurium strains was determined according to the method previously described (26, 27) . The content of CYP proteins in S. typhimurium cells was determined by Fe 2＋ CO versus Fe 2＋ diŠerence spectra, according to the method of Omura and Sato (28) .
To determine NPR expression levels, the activity of NPR in sonicated bacterial cells was measured with cytochrome c as an electron acceptor by measuring the absorbance change at 550 nm at 209 C according to the method of Phillips and Langdon (29) . The expression levels of CYP1A1, 1B1, 1A2 and 3A4 enzymes were determined to be approximately 110, 330, 110, and 110 nmol/L culture, respectively. NADPH-cytochrome c reduction activities in OY1022/1A1, OY1022/1B1, OY1022/1A2, and OY1022/3A4 strains were found to be 120, 30, 26, and 23 unit/L culture, respectively. Neither CYP protein nor NADPH-cytochrome c reduction activity was detected in S. typhimurium OY1022/ pCW strain.
umu assay: umu assay was carried out according to the procedure described by Oda et al. (30) . The overnight culture was diluted 100-fold with TGA medium (1 z Bactotryptone (w/v), 0.5z NaCl (w/v), 0.2z glucose (w/v), and 20 mg/mL ampicillin). The culture was incubated for 1h at 379 C and 1-mL aliquots of TGA culture (OD600: 0.25-0.3) and 10 mL tester compound dissolved in DMSO were mixed and further incubated for 2 h. umu assay using strains expressing human CYP and O-AT enzymes: We used the method described by Aryal et al. 
Results

EŠects of NR and O-AT on cytotoxicity and induction of umuC gene expression by 3-NBA in Salmonella tester strains:
The sensitivity of S. typhimurium TA1535/pSK1002 harboring the umuC'-'lacZ fusion gene, NM1000, NM2000, NM2009, and NM3009 strains toward cytotoxicity and genotoxicity of 3-NBA were examined ( Fig. 1 ). 3-NBA was found to be highly cytotoxic and genotoxic in a concentration-dependent fashion in the O-AT-overexpressing strain NM2009, and NRand O-AT-overexpressing strain NM3009. Sensitivities in cytotoxicity and genotoxicity in TA1535/pSK1002 (parental strain), NM1000 (nitroreductase-deˆcient strain), and NM2000 (O-AT-deˆcient strain) were similar ( Fig. 1) .
Roles of P450 enzymes in the metabolic activation of 3-NBA: We compared the sensitivity ofˆve tester strains (OY1022/1A1, OY1022/1A2, OY1022/1B1, OY1022/3A4, and OY1022/pCW) for the induction of umuC gene expression by 3-NBA (Fig. 2) . Background levels of b-galactosidase activities in strains expressing hNPR-CYP were lower than in the parental strain; therefore, genotoxicity of 3-NBA in these strains was 
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3-NBA at a concentration of 1 nM induced 9.8-, 9.6-, 7.5-, 6.2-and 1.7-fold increases in b-galactosidase acitivity in OY1022/3A4, OY1022/1A1, OY1022/1A2, OY1022/1B1 and OY1022/pCW, respectively ( Table 2 ). These results indicated that 3-NBA was activated much more strongly in strains OY1022/3A4 and OY1022/ 1A1, and more strongly in OY1022/1A2 and OY1022/ 1B1 than the parental strain OY1022/pCW.
Discussion
We have previously reported a simple SOS/umu assay, which uses the measurement of b-galactosidase activity to detect umuC gene expression (30). This system was developed to detect a wide range of carcinogenic mutagens (30, 33) as well as the genotoxic activity of complex mixture samples such as environmental pollution (34) , river and industrial wastewater (35, 36) and foodstuŠs (37) . Furthermore, we have shown that the umu test system, for which we constructed the nitroreductase-and O-acetyltransferase-overproducing NM3009 strain and O-acetyltransferase-overproducing NM2009 strain, is hypersensitive to the genotoxicity of nitroarenes (38) and aromatic amines (39) . In this study, we determined the genotoxicity of 3-NBA by using these umu tester strains developed in our laboratory. We found that NM2009 and NM3009 strains exhibited high sensitivity to the cytotoxic and genotoxic eŠects of 3-NBA (Fig. 1) . The results suggest that 3-NBA is bioactivated to the ultimate reactive metabolite(s) via nitroreduction followed by O-acetylation. The result is consistent with the results of an early study (4) , which reported that 3-NBA is a potent mutagen in the S. typhimurium YG1024 strain overexpressing O-acetyltransferase. The order of sensitivity in the cytotoxicity of bacterial strains is almost parallel to that in genotoxicity. Molecular species that exhibit cytotoxicity might be the same as those exhibiting genotoxicity.
In the previous study, we showed that 1-nitropyrene (1-NP), a nitropolycyclic aromatic hydrocarbon, can be activated by human CYP1B1 to a genotoxic compound via nitroreduction/O-acetylation at low substrate concentrations by using a umu test system that added CYP enzymes from the outside. This in‰uence should not be disregarded because nitroreductase is deˆcient in human cells, although 1-NP is activated by nitroreductase and O-AT existed in bacteria. Therefore, we developed a strain deˆcient in nitroreductase and O-AT. To clarify the roles of CYPs and NPR in metabolic activation of 3-NBA, we used strain OY1022, which is deˆcient in NR and probably O-AT. We introduced two plasmids into the YO1022 strain, one carrying both CYP and NPR cDNA in a biocistronic construct under control of an IPTG-inducible double tac promoter and pOA102, carrying bacterial O-AT and the umuC'-'lacZ fusion gene, and established four new umu tester strains, namely S. typhimurium OY1022/1A1, OY1022/1A2, OY1022/ 1B1 and OY1022/3A4.
In this study, the genotoxicity of 3-NBA was investigated in the umu assay using these strains. Among the strains used, OY1022/1A1 (expressing CYP1A1), OY1022/3A4 (expressing CYP3A4), OY1022/1A2 (expressing CYP1A2), and OY1022/1B1 (expressing CYP1B1), exhibited high genotoxic activity with 3-NBA, suggesting that human CYP1A1, 3A4, 1A2, and 1B1 are capable of e‹ciently bioactivating 3-NBA with co-expression of NPR (Table 2 ). Bieler et al. (40) have demonstrated that using the 32 P-postlabeling assay, DNA binding of 3-NBA increased signiˆcantly in V79 cells expressing human CYP3A4 in conjunction with human NPR, but not in V79 cells expressing human CYP1A1 alone. We used OY1022/1A1 strain expressing human CYP1A1 and NPR, and found that it activated 3-NBA. Thus, metabolic activation by 3-NBA could also be attributed to NPR. In fact, we observed that 3-NBA can be activated by NPR in OY1022/pOR (expressing human NPR), although the genotoxic activity of 3-NBA with the NPR-expressing strain was about 2fold lower than with CYP3A4/hNPR-or CYP1A1/ hNPR-expressing strains (data not shown). Taken together, these results supported the view that 3-NBA is mainly bioactivated by CYP1A1 and 3A4 in humans, followed by CYP1A2 and 1B1.
Human exposure to 3-NBA is thought to occur primarily through the respiratory tract. Although CYP contents in the human lung tissue are lower than in the liver, CYP enzymes in the lung may play a crucial role in extrahepatic activation of 3-NBA. Human CYP1A1 is expressed predominantly in extrahepatic organs, such as the lungs and mammary glands (41) . Although human CYP3A4 is the most abundant CYP in human liver and the small intestine, it is expressed in only about 20z of individuals (42) . Thus, bioactivation of 3-NBA in human lung cells may be responsible for potential human risk. Furthermore, with tester strains expressing human N,O-acetyltransferase and sulfotransferase enzymes, it is necessary to investigate whether N-OH-ABA, a 3-NBA-reduced metabolite, is further activated by acetylation or sulfation.
3-NBA is metabolized essentially via two pathways. In bacteria, 3-NBA is mainly activated by nitroreduction and O-acetylation, whereas in humans, it is probably activated by nitroreduction due to CYP1A1, 3A4, 1A2, and 1B1 and NPR, followed by O-acetylation. Based on the presentˆndings, we proposed a model of the metabolic pathways of 3-NBA (Fig. 3) .
In summary, we established new umu tester strains of S. typhimurium OY1022/1A1, OY1022/1A2, OY1022/ 1B1, and OY1022/3A4, which express four respective human CYP enzymes, NPR and bacterial O-AT, to clarify the role of human CYP enzyme in the bioactivation of 3-NBA to genotoxic metabolites. Using these tester strains, we demonstrated that genotoxic activation of 3-NBA can be catalyzed by human CYP3A4, 1A1, 1A2, and 1B1 and NPR to a genotoxin(s) in the presence of bacterial O-AT, probably via nitroreduction.
